{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:09:16Z","timestamp":1783472956008,"version":"3.55.0"},"reference-count":34,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:00:00Z","timestamp":1478044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"PCSS-MAT project"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec><jats:title>Background and Objectives<\/jats:title><jats:p>The Providers\u2019 Clinical Support System for Medication Assisted Treatment (PCSS\u2010MAT) initiative focuses on training and mentoring health professionals in the treatment of opioid use disorders (OUD) using pharmacological strategies. Led by the American Academy of Addiction Psychiatry (AAAP), PCSS\u2010MAT is a consortium representing four of the five national professional organizations authorized by DATA 2,000\u2014AAAP, American Osteopathic Academy of Addiction Medicine, American Psychiatric Association, and American Society of Addiction Medicine. DATA organizations are authorized to train physicians to prescribe buprenorphine for OUD treatment. The primary aim of PCSS\u2010MAT is to substantially increase evidence\u2010based practices with medications for OUD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This review describes the development of PCSS\u2010MAT, an ongoing national initiative funded by the Substance Abuse and Mental Health Services Administration (SAMHSA), to address the training needs posed by this critical public health problem. Core initiatives include: (1) Training and mentoring activities for primary care physicians; (2) Outreach to multidisciplinary professional organizations, (3) Creating a resource portal for families, patients, and communities for OUD treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Educational outreach to providers addresses the needs of patients with OUD and common co\u2010occurring psychiatric and medical disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>The overall scope of PCSS\u2010MAT is to increase access to evidence\u2010based treatment of substance use disorders as a public health priority. Recently enacted legislation requires office\u2010based opioid treatment programs to offer all Food and Drug Administration\u2010approved (FDA) forms of MAT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Scientific Significance<\/jats:title><jats:p>Working with health care providers to effectively deliver MAT is key to integrating behavioral and physical medicine. (Am J Addict 2016;25:603\u2013609)<\/jats:p><\/jats:sec>","DOI":"10.1111\/ajad.12454","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T17:07:26Z","timestamp":1478106446000},"page":"603-609","source":"Crossref","is-referenced-by-count":48,"title":["A review of a national training initiative to increase provider use of MAT to address the opioid epidemic"],"prefix":"10.1111","volume":"25","author":[{"given":"Frances R.","family":"Levin","sequence":"first","affiliation":[{"name":"New York State Psychiatric Institute &amp; Department of Psychiatry Columbia University New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bisaga","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute &amp; Department of Psychiatry Columbia University New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Columbia University New York New York"},{"name":"Alkermes, Inc. Waltham Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Robin","family":"Williams","sequence":"additional","affiliation":[{"name":"New York State Psychiatric Institute &amp; Department of Psychiatry Columbia University New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Cates\u2010Wessel","sequence":"additional","affiliation":[{"name":"American Academy of Addiction Psychiatry East Providence Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,11,2]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1975-3"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03575.x"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0193841X07307315"},{"key":"e_1_2_9_5_1","unstructured":"Substance Abuse and Mental Health Services Administration (2014). National Survey of Substance Abuse Treatment Services (N\u2010SSATS): 2013. HHS Publication No. (SMA) 14\u20134890. Rockville MD."},{"key":"e_1_2_9_6_1","unstructured":"Whitehouse.gov(2016).https:\/\/www.whitehouse.gov\/the\u2010press\u2010office\/2016\/03\/29\/remarks\u2010president\u2010panel\u2010discussion\u2010national\u2010prescription\u2010drug\u2010abuse\u2010and Accessed 4\/19\/16."},{"key":"e_1_2_9_7_1","volume-title":"Monitoring the Future National Survey Results on Drug Use From the Monitoring the Future Study, 1975\u20132001. Volume I: Secondary School Students","author":"Johnston LD","year":"2008"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.05.033"},{"key":"e_1_2_9_9_1","first-page":"S235","article-title":"Cost and utilization outcomes of opioid dependence treatments","volume":"17","author":"Baser O","year":"2011","journal-title":"Am J Manag Care"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta11090"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.05.021"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5945"},{"key":"e_1_2_9_13_1","first-page":"586","article-title":"Impact of interim methadone maintenance on HIV risk behaviors","volume":"87","author":"Wilson ME","year":"2010","journal-title":"J Urban Med"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550880902772373"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.002238.x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-3147.91934"},{"key":"e_1_2_9_17_1","first-page":"14","volume-title":"National Survey of Substance Abuse Treatment Services (N\u2010SSATS): 2013","year":"2014"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022164"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201300256"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1604223"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-008-0064-8"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280377"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1062457"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.06.005"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.4450"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2015.76.143"},{"key":"e_1_2_9_27_1","article-title":"Availability without accessibility? State Medicaid coverage and authorization requirements for opioid dependence medications","author":"Rinaldo S","year":"2013","journal-title":"The Avisa Group"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2010.01.003"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000246209.18777.14"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.01.032"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-010-1377-y"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14546-1"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.03.005"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1595"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.2421"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajad.12454","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajad.12454","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajad.12454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T15:13:18Z","timestamp":1696518798000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajad.12454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,2]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1111\/ajad.12454"],"URL":"https:\/\/doi.org\/10.1111\/ajad.12454","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,2]]}}}